keyword
https://read.qxmd.com/read/38655092/molecular-targeted-therapies-for-cutaneous-squamous-cell-carcinoma-recent-developments-and-clinical-implications
#1
REVIEW
Harpreet Singh, Hitesh Chopra, Inderbir Singh, Sourav Mohanto, Mohammed Gulzar Ahmed, Shruti Ghumra, Anmol Seelan, Manisha Survase, Arvind Kumar, Amrita Mishra, Arun Kumar Mishra, Mohammad Amjad Kamal
Cutaneous Squamous Cell Carcinoma (cSCC) is a common and potentially fatal type of skin cancer that poses a significant threat to public health and has a high prevalence rate. Exposure to ultraviolet radiation on the skin surface increases the risk of cSCC, especially in those with genetic syndromes like xerodermapigmentosum and epidermolysis bullosa. Therefore, understanding the molecular pathogenesis of cSCC is critical for developing personalized treatment approaches that are effective in cSCC. This article provides a comprehensive overview of current knowledge of cSCC pathogenesis, emphasizing dysregulated signaling pathways and the significance of molecular profiling...
2024: EXCLI Journal
https://read.qxmd.com/read/38655042/evaluation-of-the-effect-of-photobiomodulation-on-radiation-induced-xerostomia-in-head-and-neck-cancer-patients-a-randomized-clinical-trial
#2
JOURNAL ARTICLE
Pegah Mosannen Mozaffari, Zahra Delavarian, Reza Fekrazad, Azar Fani Pakdel, Mahdokht Rashed Mohassel, Mohammad Taghi Shakeri, Ala Ghazi
Introduction: Radiotherapy-induced xerostomia is an important side effect of head and neck cancer (HNC) treatment. Photobiomodulation (PBM) is one of the new emerging methods for preventing or reducing this problem. The aim of this study is to evaluate the effect of PBM on radiation-induced xerostomia in HNC patients. Methods: Thirty-seven patients with HNC who were referred for radiotherapy to Mashhad cancer center. In the case group, an infrared diode laser was used in contact mode on 16 points (covering minor and major salivary glands)...
2024: Journal of Lasers in Medical Sciences
https://read.qxmd.com/read/38653735/biosynthesized-metallic-nanoparticles-a-new-era-in-cancer-therapy
#3
REVIEW
Nabila Abdul Gaffar, Mavia Zahid, Akleem Asghar, Muhammad Faisal Shafiq, Seemal Jelani, Farah Rehan
Cancer remains a global health crisis, claiming countless lives throughout the years. Traditional cancer treatments like chemotherapy and radiation often bring about severe side effects, underscoring the pressing need for innovative, more efficient, and less toxic therapies. Nanotechnology has emerged as a promising technology capable of producing environmentally friendly anticancer nanoparticles. Among various nanoparticle types, metal-based nanoparticles stand out due to their exceptional performance and ease of use in methods of imaging...
April 23, 2024: Archiv der Pharmazie
https://read.qxmd.com/read/38653627/advancing-in-vivo-assessment-of-red-blood-cell-transfusions-a-call-for-radiation-free-methods-in-transfusion-medicine
#4
REVIEW
Mahsa Yazdanbakhsh, Jason P Acker
RBC transfusions are a vital clinical therapy to treat anemic patients. The in vivo assessment of red blood cell (RBC) quality post-transfusion is critical to ensuring that the introduction of new RBC products meet established regulatory and clinical quality requirements. Although in vitro quality control testing is routinely performed by blood manufacturers, it is crucial that in vivo tests are performed during the evaluation and regulatory process of new RBC products. This article reviews existing in vivo techniques, like chromium-51 labelling and biotinylation, for determining the circulation and survival of RBCs, and advocates for a move to radiation-free methods...
April 17, 2024: Transfusion and Apheresis Science
https://read.qxmd.com/read/38653089/advances-in-glioblastoma-multiforme-integrating-therapy-and-pathology-perspectives
#5
REVIEW
Seyed Hossein Shahcheraghi, Maliheh Alimardani, Malihe Lotfi, Marzieh Lotfi, Vladimir N Uversky, Stephanie Tamdem Guetchueng, Sushesh Shrivastsa Palakurthi, Nitin B Charbe, Altijana Hromić-Jahjefendić, Alaa A A Aljabali, Manoj M Gadewar, Sumira Malik, Rohit Goyal, Mohamed El-Tanani, Vijay Mishra, Yachana Mishra, Murtaza M Tambuwala
Glioblastoma, a highly lethal form of brain cancer, is characterized by its aggressive growth and resistance to conventional treatments, often resulting in limited survival. The response to therapy is notably influenced by various patient-specific genetic factors, underscoring the disease's complexity. Despite the utilization of diverse treatment modalities such as surgery, radiation, and chemotherapy, many patients experience local relapse, emphasizing the critical need for improved therapeutic strategies to effectively target these formidable tumors...
April 5, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38647995/update-on-percutaneous-ablation-for-sarcoma
#6
REVIEW
Ahmad Parvinian, Scott M Thompson, John J Schmitz, Brian T Welch, Rebecca Hibbert, Daniel A Adamo, A Nicholas Kurup
PURPOSE OF REVIEW: To provide an update on the current state of percutaneous thermal ablation in the treatment of sarcoma. RECENT FINDINGS: Data continue to accrue in support of ablation for local control and palliation of specific sarcoma subtypes such as extra-abdominal desmoid fibromatosis and for broader indications such as the treatment of oligometastatic disease. The synergistic possibilities of various combination therapies such as cryoablation and immunotherapy represent intriguing areas of active investigation...
April 22, 2024: Current Oncology Reports
https://read.qxmd.com/read/38645602/plasma-cell-myeloma-in-a-9-year-old-male-case-report-and-literature-review
#7
Kato Ronald, Ambaru Jacinta, Ssebagala Umaru
KEY CLINICAL MESSAGE: Plasma cell myeloma is a rare entity in the pediatric population. The peak incidence is in the seventh decade, with less than 2% of cases occurring in patients under the age of 40. It is worth noting that any destructive bony lesion in a child should be investigated. ABSTRACT: Plasma cell myeloma (multiple myeloma) is the most common form of plasma cell neoplasm. It is a rare entity in young patients. The peak incidence is in the seventh decade, with less than 2% of cases occurring in patients under the age of 40...
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38644713/smart-nanobiomaterials-for-gene-delivery-in-localized-cancer-therapy-an-overview-from-emerging-materials-and-devices-to-clinical-applications
#8
JOURNAL ARTICLE
Armin Shamaeizadeh, Anahita Beigi, Seyed Morteza Naghib, Maryam Tajabadi, Mehdi Rahmanian, M R Mozafari
Researchers in various fields continue to discover improved ways of local delivery of drugs to specific locations and try to increase the efficiency of these methods. Extensive research has been done on smart nano-biomaterials for drug delivery systems (DDS) in different dimensions. With the advancement of biomedical nanotechnology, conventional smart DDS with stimuli- responsive capability has been developed. Smart nano-biomaterials can respond to environmental changes caused by endogenous or exogenous elements: endogenous factors such as environmental pH, temperature gradient, enzymes, oxidation, and reduction potential...
April 19, 2024: Current Cancer Drug Targets
https://read.qxmd.com/read/38643837/e2f1-regulated-usp5-contributes-to-the-tumorigenic-capacity-of-glioma-stem-cells-through-the-maintenance-of-oct4-stability
#9
JOURNAL ARTICLE
Xiao Jiang, Hongtao You, Yixuan Niu, Yudan Ding, Zhengxin Chen, Huibo Wang, Yuan Xu, Peng Zhou, Li Wei, Danni Deng, Lian Xue, Ya Peng, Yilin Yang, Ligang Fan, Naiyuan Shao
Mesenchymal glioma stem cells (MES GSCs) are a subpopulation of cells in glioblastoma (GBM) that contribute to a worse prognosis owing to their highly aggressive nature and resistance to radiation therapy. Here, OCT4 is characterized as a criticial factor in sustaining the stemness phenotype of MES GSC. We find that OCT4 is expressed intensively in MES GSC and is intimately associated with poor prognosis, moreover, OCT4 depletion leads to diminished invasive capacity and impairment of the stem phenotype in MES GSC...
April 19, 2024: Cancer Letters
https://read.qxmd.com/read/38641474/natural-history-and-health-care-burden-of-non-curative-treatment-for-muscle-invasive-bladder-cancer
#10
JOURNAL ARTICLE
Haim Herzberg, Yossi Ventura, Karin Lifshitz, Ziv Savin, Shay Golan, Jack Baniel, Ofer Yossepowitch, Roy Mano
OBJECTIVE: Muscle-invasive bladder cancer is an aggressive disease. Yet, many patients, especially those with advanced age and multiple comorbidities, do not receive treatment with curative intent. We evaluated the disease course and health care burden of these patients. MATERIALS AND METHODS: Bi-center, retrospective analysis of patients diagnosed with muscle-invasive bladder cancer who did not undergo curative-intent treatment (radical cystectomy or trimodal therapy) between 2016 and 2021...
April 18, 2024: Urologic Oncology
https://read.qxmd.com/read/38638599/patients-with-spondylodiscitis-following-chemoradiotherapy-for-head-and-neck-cancer-in-a-portuguese-cancer-hospital-a-case-report
#11
Diana Pessoa, Inês Vicente, Carolina Pereira, Ana Pina, Pedro Freitas, Alexandra Borges, Isabel Sargento
INTRODUCTION: Head and neck cancer is an umbrella term for tumor manifestations across the head and neck regions, including the oral cavity, pharynx (including the naso, oro, and hypopharynx), larynx, and sinuses. Treatment options for head and neck cancer include surgery, radiation therapy, chemotherapy, and immunotherapy, with specific treatment plans depending upon individual tumor location and staging, together with overall patient health status. Furthermore, definitive chemoradiotherapy (CRT) has emerged as a highly effective therapeutic option for locoregional advanced head and neck squamous cell cancer...
2024: Case Reports in Oncology
https://read.qxmd.com/read/38636951/a-prognostic-survival-model-incorporating-patient-reported-outcomes-for-transplant-ineligible-patients-with-multiple-myeloma
#12
JOURNAL ARTICLE
Hira Mian, Hsien Seow, Amaris K Balitsky, Matthew C Cheung, Anastasia Gayowsky, Jason Tay, Tanya M Wildes, Arleigh McCurdy, Alissa Visram, Irwindeep Sandhu, Rinku Sutradhar
Developing prognostic tools specifically for patients themselves represents an important step in empowering patients to engage in shared decision-making. Incorporating patient-reported outcomes may improve the accuracy of these prognostic tools. We conducted a retrospective population-based study of transplant-ineligible (TIE) patients with multiple myeloma (MM) diagnosed between January 2007 and December 2018. A multivariable Cox regression model was developed to predict the risk of death within 1-year period from the index date...
April 18, 2024: Oncologist
https://read.qxmd.com/read/38636338/syk-dependent-homologous-recombination-activation-promotes-cancer-resistance-to-dna-targeted-therapy
#13
JOURNAL ARTICLE
Qin Zhou, Xinyi Tu, Xiaonan Hou, Jia Yu, Fei Zhao, Jinzhou Huang, Jake Kloeber, Anna Olson, Ming Gao, Kuntian Luo, Shouhai Zhu, Zheming Wu, Yong Zhang, Chenyu Sun, Xiangyu Zeng, Kenneth J Schoolmeester, John S Weroha, Xiwen Hu, Yanxia Jiang, Liewei Wang, Robert W Mutter, Zhenkun Lou
Enhanced DNA repair is an important mechanism of inherent and acquired resistance to DNA targeted therapies, including poly ADP ribose polymerase (PARP) inhibition. Spleen associated tyrosine kinase (Syk) is a non-receptor tyrosine kinase acknowledged for its regulatory roles in immune cell function, cell adhesion, and vascular development. This study presents evidence indicating that Syk expression in high-grade serous ovarian cancer and triple-negative breast cancers promotes DNA double-strand break resection, homologous recombination (HR), and subsequent therapeutic resistance...
April 16, 2024: Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
https://read.qxmd.com/read/38628665/the-radiation-therapy-technology-evidence-matrix-a-framework-to-visualize-evidence-development-for-innovations-in-radiation-therapy
#14
JOURNAL ARTICLE
Sarah Edwards, Marco Luzzara, Veronica Dell'Acqua, John Christodouleas
Clinical evidence is crucial in enabling the judicious adoption of technological innovations in radiation therapy (RT). Pharmaceutical evidence development frameworks are not useful for understanding how technical advances are maturing. In this paper, we introduce a new framework, the Radiation Therapy Technology Evidence Matrix (rtTEM), that helps visualize how the clinical evidence supporting new technologies is developing. The matrix is a unique 2D model based on the R-IDEAL clinical evaluation framework...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38628522/primary-extranodal-marginal-zone-mucosa-associated-lymphoid-tissue-type-b-cell-lymphoma-involving-the-dura-a-case-report
#15
Ryo Hamamoto, Toshinari Kawasaki, Masashi Oda, Sosuke Sumiyoshi, Kosuke Hayashi, Tamaki Kobayashi, Yoshihiko Ioroi, Tatsuki Uchiyama, Motohiro Takayama, Masaaki Saiki
BACKGROUND: Primary extranodal marginal zone mucosa-associated lymphoid tissue-type B-cell lymphoma (EMZMBCL), which presents as a dural mass, is a rare intracranial tumor that mimics a subdural hematoma or meningioma. CASE DESCRIPTION: A 49-year-old woman presented to our hospital with transient right upper limb paresis, dysarthria for 10 min, and ongoing right upper-limb numbness. Computed tomography (CT) of the head revealed extra-axial lesions in the left frontal and parietal lobes...
2024: Surgical Neurology International
https://read.qxmd.com/read/38626516/advances-in-liposomes-loaded-with-photoresponse-materials-for-cancer-therapy
#16
REVIEW
Xianwei Zhang, Youfu Ma, Yenong Shi, Lihe Jiang, Lisheng Wang, Haroon Ur Rashid, Mingqing Yuan, Xu Liu
Cancer treatment is presently a significant challenge in the medical domain, wherein the primary modalities of intervention include chemotherapy, radiation therapy and surgery. However, these therapeutic modalities carry side effects. Photothermal therapy (PTT) and photodynamic therapy (PDT) have emerged as promising modalities for the treatment of tumors in recent years. Phototherapy is a therapeutic approach that involves the exposure of materials to specific wavelengths of light, which can subsequently be converted into either heat or Reactive Oxygen Species (ROS) to effectively eradicate cancer cells...
April 15, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38626342/oxygen-independent-radiodynamic-therapy-radiation-boosted-chemodynamics-for-reprogramming-the-tumor-immune-environment-and-enhancing-antitumor-immune-response
#17
JOURNAL ARTICLE
Yang Chen, Yong Deng, Yiran Li, Yulin Qin, Zhiguo Zhou, Hong Yang, Yun Sun
Radiodynamic therapy (RDT) has emerged as a promising modality for cancer treatment, offering notable advantages such as deep tissue penetration and radiocatalytic generation of oxygen free radicals. However, the oxygen-dependent nature of RDT imposes limitations on its efficacy in hypoxic conditions, particularly in modulating and eliminating radioresistant immune suppression cells. A novel approach involving the creation of a "super" tetrahedron polyoxometalate (POM) cluster, Fe12 -POM, has been developed for radiation boosted chemodynamic catalysis to enable oxygen-independent RDT in hypoxic conditions...
April 16, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38624164/cancer-cell-mimicking-prussian-blue-nanoplatform-for-synergistic-mild-photothermal-chemotherapy-via-heat-shock-protein-inhibition
#18
JOURNAL ARTICLE
Yun Wang, Jinling Wang, Roumei Ye, Quanyi Jin, Fengyue Yin, Nian Liu, Yubo Wang, Quan Zhang, Ting Gao, Yilin Zhao
Combined mild-temperature photothermal/chemotherapy has emerged as a highly promising modality for tumor therapy. However, its therapeutic efficacy is drastically compromised by the heat-induced overexpression of heat shock proteins (HSPs) by the cells, which resist heat stress and apoptosis. The purpose of this study was to downregulate HSPs and enhance the mild-temperature photothermal/chemotherapy effect. In detail, the colon cancer cell membrane (CT26M)-camouflaged HSP90 inhibitor ganetespib and the chemotherapeutic agent doxorubicin (DOX)-coloaded hollow mesoporous Prussian blue (HMPB) nanoplatform (named PGDM) were designed for synergistic mild photothermal/chemotherapy via HSP inhibition...
April 16, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38619338/primary-splenic-angiosarcoma-a-case-series-of-a-rare-oncological-entity-and-diagnostic-challenge
#19
JOURNAL ARTICLE
Iris Dirven, Philippe Leclercq, Lionel D'Hondt, Valentine Delmotte, Pierre Lefesvre, Hendrik Reynaert, Frederik Vandenbroucke, Magali Surmont
BACKGROUND AND PURPOSE: Primary angiosarcoma of the spleen (PAS), an exceptionally rare and aggressive neoplasm with high metastatic risk (70%-85%), is frequently diagnosed in an advanced or metastatic stage. It presents diagnostic challenges due to its nonspecific symptomatology and resemblance to benign vascular lesions in various imaging modalities. PATIENTS AND METHODS: This case series aims to clarify the diagnostic difficulties by comparing imaging characteristics (CT-scan, MRI, and [18F]FDG-PET/CT) as well as pathological findings of three PAS cases diagnosed in different stages of the diseases (localized, metastatic, and metastatic with organ failure)...
April 15, 2024: Acta Oncologica
https://read.qxmd.com/read/38615197/multicenter-evaluation-of-the-safety-and-efficacy-of-selective-internal-radiation-therapy-with-yttrium-90-resin-microspheres-in-taiwan-data-from-the-resin-registry
#20
JOURNAL ARTICLE
Rheun-Chuan Lee, Po-Chin Liang, Huei-Lung Liang, Yung-Fang Chen, Chun-Yen Yu, Pin-Nan Cheng, Chien-Fu Hung, Cheng-Yuan Hsia, Hsueh-Chou Lai, Ming-Chih Ho, Yu-Fan Cheng, Yi-Sheng Liu, Yee Chao, Chien-Hung Chen
BACKGROUND AND AIM: The REgistry of Selective Internal radiation therapy in AsiaNs (RESIN) was a multicenter, single-arm, prospective, observational study of 90 Y resin microspheres in patients with hepatocellular carcinoma (HCC) or metastatic colorectal cancer (mCRC) from Taiwan. RESIN is the first real-life clinical study of this therapy in an Asian cohort. Study objectives were to evaluate the safety and efficacy of 90 Y resin microspheres. METHODS: Adults with HCC or mCRC scheduled to receive SIRT with 90 Y resin microspheres were included...
April 13, 2024: Journal of Gastroenterology and Hepatology
keyword
keyword
94272
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.